Stanford-StartX Fund-Backed Nirmidas Biotech Raises $2 Million for Diagnostic Research Tools

Palo Alto, CA (PRWEB) August 18, 2014 Nirmidas Biotech, Inc., a diagnostic research technology company, is announcing that it has raised $ 2 million in seed round funding to commercialize its fluorescence enhancing plasmonic gold technology, called “pGOLD.” The technology platform, which significantly boosts the ability to detect disease biomarkers, is based on nearly a […]